Inovio Pharmaceuticals Inc vs Paycom Software Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Paycom Software Inc trades at $144.05 (market cap $6.98B). The key difference: Paycom Software Inc is far larger — about 78.2× Inovio Pharmaceuticals Inc's market cap, and Paycom Software Inc pays a 1% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | PAYC | |
|---|---|---|
Market Cap | $89.27M | $6.98B |
Sector | Health | Technology |
52-Week High | $2.87 | $238.80 |
52-Week Low | $1.05 | $113.59 |
Enterprise Value | $60.28M | $7.59B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →